Clinical Trial Update: Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating first-line panobinostat with etoposide and cisplatin for extensive-stage small cell lung cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Panobinostat (Panobinostat)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Lung Cancer | Phase 1 | Status: WITHDRAWN